Inventor
SEWARD EILEEN MARY
GB30 patents
⚠️ This page may combine multiple inventors who share the name “SEWARD EILEEN MARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
18 patentsUS6172077B1Jan 9, 2001
Spiro-azacyclic derivatives and their use as therapeutic agents
MERCK SHARP & DOHME149 citations97
US6114315ASep 5, 2000
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
MERCK SHARP & DOHME26 citations92
US5952315ASep 14, 1999
Use of NK-1 receptor antagonists for treating bipolar disorders
MERCK SHARP & DOHME34 citations92
US5728695AMar 17, 1998
Spiroketal derivatives, compositions containing them and their use as therapeutic agents
MERCK SHARP & DOHME26 citations92
US6046195AApr 4, 2000
Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
MERCK SHARP & DOHME26 citations90
US7638629B2Dec 29, 2009
Piperidines and related compounds for treatment of alzheimer's disease
MERCK SHARP & DOHME13 citations83
US6271230B1Aug 7, 2001
Use of NK-1 receptor antagonists for treating cognitive disorders
MERCK SHARP & DOHME6 citations74
US6071927AJun 6, 2000
Spiro-piperidine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME13 citations74
US5925627AJul 20, 1999
Use of NK-1 receptor antagonists for treating movement disorders
MERCK SHARP & DOHME7 citations74
US6489343B2Dec 3, 2002
Tetrahydropyran derivatives and their use as therapeutic agents
MERCK SHARP & DOHME9 citations73
US6087348AJul 11, 2000
Use of NK-1 receptor antagonists for treating stress disorders
MERCK SHARP & DOHME3 citations63
US5919781AJul 6, 1999
Use of NK-1 receptor antogonists for treating substance use disorders
MERCK SHARP & DOHME5 citations63
US5665883ASep 9, 1997
Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
MERCK SHARP & DOHME6 citations63
US6458830B1Oct 1, 2002
Tetrahydropyran derivatives and their use as therapeutic agents
MERCK SHARP & DOHME7 citations62
US5747491AMay 5, 1998
Morpholine derivatives and their use as antagonists of tachikinins
MERCK SHARP & DOHME3 citations61
US7101892B2Sep 5, 2006
Sulfone derivatives as 5-HT7 receptor ligands
MERCK SHARP & DOHME2 citations60
US5877316AMar 2, 1999
Morpholine derivatives, compositions containing them and their use as therapeutic agents
MERCK SHARP & DOHME6 citations60
US6096729AAug 1, 2000
Use of NK-1 receptor antagonists for treating amnestic disorders
MERCK SHARP & DOHME0 citations52
VANDRIA SA
4 patentsUS11820751B2Nov 21, 2023
Urolithin derivatives and methods of use thereof
VANDRIA SA3 citations69
US12473269B2Nov 18, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
US12358884B2Jul 15, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
US12351567B2Jul 8, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
CASTANEDO GEORGETTE
3 patentsUS8394796B2Mar 12, 2013
Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE8 citations82
US8173650B2May 8, 2012
Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE7 citations82
US8158625B2Apr 17, 2012
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE6 citations71